Literature DB >> 19635462

Subcellular localization of adenosine kinase in mammalian cells: The long isoform of AdK is localized in the nucleus.

Xianying Amy Cui1, Bhag Singh, Jae Park, Radhey S Gupta.   

Abstract

Two isoforms of adenosine kinase (AdK) have been identified in mammalian organisms with the long isoform (AdK-long) containing extra 20-21 amino acids at the N-terminus (NTS). The subcellular localizations of these isoforms are not known and they contain no identifiable targeting sequence. Immunofluorescence labeling of mammalian cells expressing either only AdK-long or both isoforms with AdK-specific antibody showed only nuclear labeling or both nucleus and cytoplasmic labeling, respectively. The AdK-long and -short isoforms fused at the C-terminus with c-myc epitope also localized in the nucleus and cytoplasm, respectively. Fusion of the AdK-long NTS to green fluorescent protein also resulted in its nuclear localization. AdK-long NTS contains a cluster of conserved amino acids (PKPKKLKVE). Replacement of KK in this sequence with either AA or AD abolished its nuclear localization capability, indicating that this cluster likely serves as a nuclear localization signal. AdK in nucleus is likely required for sustaining methylation reactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635462     DOI: 10.1016/j.bbrc.2009.07.106

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  31 in total

1.  Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy.

Authors:  Eleonora Aronica; Emanuele Zurolo; Anand Iyer; Marjolein de Groot; Jasper Anink; Caterina Carbonell; Erwin A van Vliet; Johannes C Baayen; Detlev Boison; Jan A Gorter
Journal:  Epilepsia       Date:  2011-06-02       Impact factor: 5.864

2.  Adenosine kinase as a target for therapeutic antisense strategies in epilepsy.

Authors:  Panos Theofilas; Sukhmani Brar; Kerry-Ann Stewart; Hai-Ying Shen; Ursula S Sandau; David Poulsen; Detlev Boison
Journal:  Epilepsia       Date:  2011-01-28       Impact factor: 5.864

3.  Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies.

Authors:  Utthara Nayar; Jouliana Sadek; Jonathan Reichel; Denise Hernandez-Hopkins; Gunkut Akar; Peter J Barelli; Michelle A Sahai; Hufeng Zhou; Jennifer Totonchy; David Jayabalan; Ruben Niesvizky; Ilaria Guasparri; Duane Hassane; Yifang Liu; Shizuko Sei; Robert H Shoemaker; J David Warren; Olivier Elemento; Kenneth M Kaye; Ethel Cesarman
Journal:  J Clin Invest       Date:  2017-05-15       Impact factor: 14.808

4.  Adenosine Kinase Deficiency Increases Susceptibility to a Carcinogen.

Authors:  Rkia El-Kharrag; Randy Owen; Detlev Boison
Journal:  J Caffeine Adenosine Res       Date:  2019-03-14

5.  Adenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replication.

Authors:  Justin P Annes; Jennifer Hyoje Ryu; Kelvin Lam; Peter J Carolan; Katrina Utz; Jennifer Hollister-Lock; Anthony C Arvanites; Lee L Rubin; Gordon Weir; Douglas A Melton
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-15       Impact factor: 11.205

6.  Adenosine Kinase Expression in the Frontal Cortex in Schizophrenia.

Authors:  Cassidy L Moody; Adam J Funk; Emily Devine; Ryan C Devore Homan; Detlev Boison; Robert E McCullumsmith; Sinead M O'Donovan
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

Review 7.  Adenosine dysfunction in epilepsy.

Authors:  Detlev Boison
Journal:  Glia       Date:  2011-12-22       Impact factor: 7.452

Review 8.  Glial adenosine kinase--a neuropathological marker of the epileptic brain.

Authors:  Eleonora Aronica; Ursula S Sandau; Anand Iyer; Detlev Boison
Journal:  Neurochem Int       Date:  2013-02-04       Impact factor: 3.921

Review 9.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

10.  Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis.

Authors:  Rebecca L Williams-Karnesky; Ursula S Sandau; Theresa A Lusardi; Nikki K Lytle; Joseph M Farrell; Eleanor M Pritchard; David L Kaplan; Detlev Boison
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.